Clinical Efficacy of Acetaminophen in Mechanical Ventilation in Children With New Coronary Pneumonia
- Conditions
- Acetaminophen,Mechanical Ventilation,Critically Ill Children
- Interventions
- Device: Paracetamol injection
- Registration Number
- NCT05691088
- Lead Sponsor
- The Second Clinical Medical College of Jinan University
- Brief Summary
Patients were randomized to receive either paracetamol during mechanical ventilation. When patients were randomized to receive paracetamol (40 mg/kg per day in 4 doses), a placebo infusion of normal saline was administered continuously at the same rate as an equivalent infusion. Placebos could not be distinguished from the active study drug in color, odor, or viscosity.
In both study groups, IMV was maintained with sufentanil (0-0.2 mcg/kg/h), propofol (0-4 mg/kg/h), and dexmedetomidine (0-1 mcg/kg/h). Assessment of sedation levels by the bedside nurse using the FLACC pain scale to determine if the child is adequately comfortable or in need of more or less medication to maintain adequate ventilation. Assessment of sedation levels by the bedside nurse using the FLACC pain scale (every 6 hours as a minimum time interval).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 128
- Inclusion criteria were body weight greater than 1500 g; and mechanically ventilated patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
- Exclusion criteria were admitted with a tracheostomy in situ; extracorporeal membrane oxygenation treatment; neurologic dysfunction, hepatic dysfunction, or renal insufficiency; known allergy to or intolerance for paracetamol; and administration of paracetamol in the 24 hours prior to mechanical ventilation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group A Paracetamol injection Paracetamol injection
- Primary Outcome Measures
Name Time Method Mechanical ventilation time an average of 5 days
- Secondary Outcome Measures
Name Time Method Length of ICU stay time an average of 1 week
Trial Locations
- Locations (1)
Windo Medical
🇨🇳Shenzhen, Guangdong, China